CK

Chandra Kant Goel

Active Director Director DIN 08432451
DIN 08432451 First appointment Apr 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Chandra Kant Goel

Data last updated:

Chandra Kant Goel is a Director at Olic Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Olic Pharmaceuticals Private Limited reported revenue of ₹14.3 Lakh (FY 2017).

DIN 08432451
Primary Designation Director
Industry Trading
First Appointment 24 Apr 2019
Oldest Company Age 15 yrs
Largest company Olic Pharmaceuticals Private Limited · ₹14.3 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olic Pharmaceuticals Private Limited U74900UP2010PTC042957
Director24 Apr 20192010₹14.3 Lakh (FY 2017)Active

Board colleagues of Chandra Kant Goel

NameDINCompanyDesignation
Om Tripathi Prakash05154816Olic Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Olic Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandra Kant Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Kant Goel

Chandra Kant Goel currently holds 1 directorship: Olic Pharmaceuticals Private Limited (Director, since 24 Apr 2019, revenue ₹14.3 Lakh (FY 2017)).

Chandra Kant Goel was first appointed on 24 Apr 2019 as Director at Olic Pharmaceuticals Private Limited.

The current boards of Chandra Kant Goel's companies include Om Tripathi Prakash (Olic Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available